• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床 WGS 作为遗传疾病诊断检测的敏感性和覆盖度分析

Characterizing sensitivity and coverage of clinical WGS as a diagnostic test for genetic disorders.

机构信息

BGI Genomics, BGI-Shenzhen, Shenzhen, 518083, China.

Tianjin Medical Laboratory, BGI-Tianjin, BGI-Shenzhen, Tianjin, 300308, China.

出版信息

BMC Med Genomics. 2021 Apr 13;14(1):102. doi: 10.1186/s12920-021-00948-5.

DOI:10.1186/s12920-021-00948-5
PMID:33849535
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8045368/
Abstract

BACKGROUND

Due to its reduced cost and incomparable advantages, WGS is likely to lead to changes in clinical diagnosis of rare and undiagnosed diseases. However, the sensitivity and breadth of coverage of clinical WGS as a diagnostic test for genetic disorders has not been fully evaluated.

METHODS

Here, the performance of WGS in NA12878, the YH cell line, and the Chinese trios were measured by assessing their sensitivity, PPV, depth and breadth of coverage using MGISEQ-2000. We also compared the performance of WES and WGS using NA12878. The sensitivity and PPV were tested using the family-based trio design for the Chinese trios. We further developed a systematic WGS pipeline for the analysis of 8 clinical cases.

RESULTS

In general, the sensitivity and PPV for SNV/indel detection increased with mean depth and reached a plateau at an ~ 40X mean depth using down-sampling samples of NA12878. With a mean depth of 40X, the sensitivity of homozygous and heterozygous SNPs of NA12878 was > 99.25% and > 99.50%, respectively, and the PPV was 99.97% and 98.96%. Homozygous and heterozygous indels showed lower sensitivity and PPV. The sensitivity and PPV were still not 100% even with a mean depth of ~ 150X. We also observed a substantial variation in the sensitivity of CNV detection across different tools, especially in CNVs with a size less than 1 kb. In general, the breadth of coverage for disease-associated genes and CNVs increased with mean depth. The sensitivity and coverage of WGS (~ 40X) was better than WES (~ 120X). Among the Chinese trios with an ~ 40X mean depth, the sensitivity among offspring was > 99.48% and > 96.36% for SNP and indel detection, and the PPVs were 99.86% and 97.93%. All 12 previously validated variants in the 8 clinical cases were successfully detected using our WGS pipeline.

CONCLUSIONS

The current standard of a mean depth of 40X may be sufficient for SNV/indel detection and identification of most CNVs. It would be advisable for clinical scientists to determine the range of sensitivity and PPV for different classes of variants for a particular WGS pipeline, which would be useful when interpreting and delivering clinical reports.

摘要

背景

由于成本降低和无与伦比的优势,WGS 可能会导致对罕见和未确诊疾病的临床诊断发生变化。然而,WGS 作为遗传疾病诊断测试的灵敏度和覆盖范围尚未得到充分评估。

方法

在这里,通过使用 MGISEQ-2000 评估其灵敏度、PPV、深度和覆盖范围,测量了 WGS 在 NA12878、YH 细胞系和中国三家中的性能。我们还使用 NA12878 比较了 WES 和 WGS 的性能。使用基于家庭的三人群设计测试了 SNV/indel 检测的灵敏度和 PPV。我们进一步为 8 例临床病例开发了系统的 WGS 分析管道。

结果

总体而言,使用 down-sampling 的 NA12878 样本,随着平均深度的增加,SNV/indel 检测的灵敏度和 PPV 也随之增加,并且在平均深度约为 40X 时达到平台。在平均深度为 40X 时,NA12878 的纯合和杂合 SNP 的灵敏度分别>99.25%和>99.50%,PPV 分别为 99.97%和 98.96%。纯合和杂合插入缺失显示出较低的灵敏度和 PPV。即使平均深度约为 150X,灵敏度和 PPV 仍未达到 100%。我们还观察到不同工具在检测 CNV 时的灵敏度存在很大差异,尤其是在大小小于 1kb 的 CNV 中。总体而言,与疾病相关的基因和 CNV 的覆盖范围随平均深度的增加而增加。WGS(40X)的灵敏度和覆盖范围优于 WES(120X)。在平均深度约为 40X 的中国三家中,后代的 SNP 和 indel 检测灵敏度分别>99.48%和>96.36%,PPV 分别为 99.86%和 97.93%。使用我们的 WGS 管道成功检测到 8 例临床病例中 12 个先前验证的变异。

结论

目前,平均深度为 40X 的标准可能足以检测 SNV/indel 并识别大多数 CNV。临床科学家确定特定 WGS 管道中不同类别的变异的灵敏度和 PPV 范围是明智的,这在解释和提供临床报告时将很有用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9077/8045368/a3195bb18d6b/12920_2021_948_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9077/8045368/2590ff7a3a8b/12920_2021_948_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9077/8045368/0740d346c09f/12920_2021_948_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9077/8045368/bba103fc1063/12920_2021_948_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9077/8045368/27644c506c65/12920_2021_948_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9077/8045368/a3195bb18d6b/12920_2021_948_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9077/8045368/2590ff7a3a8b/12920_2021_948_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9077/8045368/0740d346c09f/12920_2021_948_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9077/8045368/bba103fc1063/12920_2021_948_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9077/8045368/27644c506c65/12920_2021_948_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9077/8045368/a3195bb18d6b/12920_2021_948_Fig5_HTML.jpg

相似文献

1
Characterizing sensitivity and coverage of clinical WGS as a diagnostic test for genetic disorders.临床 WGS 作为遗传疾病诊断检测的敏感性和覆盖度分析
BMC Med Genomics. 2021 Apr 13;14(1):102. doi: 10.1186/s12920-021-00948-5.
2
Performance characterization of PCR-free whole genome sequencing for clinical diagnosis.无 PCR 全基因组测序在临床诊断中的性能特征分析。
Medicine (Baltimore). 2022 Mar 11;101(10):e28972. doi: 10.1097/MD.0000000000028972.
3
Whole-genome sequencing analysis of CNV using low-coverage and paired-end strategies is efficient and outperforms array-based CNV analysis.采用低覆盖度和双端测序策略进行全基因组测序分析,效率高,优于基于阵列的 CNV 分析。
J Med Genet. 2018 Nov;55(11):735-743. doi: 10.1136/jmedgenet-2018-105272. Epub 2018 Jul 30.
4
High-coverage whole-genome sequencing of the expanded 1000 Genomes Project cohort including 602 trios.对扩展的 1000 基因组项目队列进行高覆盖率全基因组测序,包括 602 个三核苷酸重复序列。
Cell. 2022 Sep 1;185(18):3426-3440.e19. doi: 10.1016/j.cell.2022.08.004.
5
Measuring coverage and accuracy of whole-exome sequencing in clinical context.测量临床环境下全外显子组测序的覆盖度和准确性。
Genet Med. 2018 Dec;20(12):1617-1626. doi: 10.1038/gim.2018.51. Epub 2018 Apr 12.
6
Test development, optimization and validation of a WGS pipeline for genetic disorders.开发、优化和验证用于遗传疾病的 WGS 管道的测试。
BMC Med Genomics. 2023 Apr 5;16(1):74. doi: 10.1186/s12920-023-01495-x.
7
Reducing INDEL calling errors in whole genome and exome sequencing data.降低全基因组和外显子组测序数据中 INDEL 调用错误。
Genome Med. 2014 Oct 28;6(10):89. doi: 10.1186/s13073-014-0089-z. eCollection 2014.
8
From cytogenetics to cytogenomics: whole-genome sequencing as a first-line test comprehensively captures the diverse spectrum of disease-causing genetic variation underlying intellectual disability.从细胞遗传学到细胞基因组学:全基因组测序作为一线检测手段,全面捕捉到导致智力障碍的遗传变异的多样谱。
Genome Med. 2019 Nov 7;11(1):68. doi: 10.1186/s13073-019-0675-1.
9
Whole-genome sequencing is more powerful than whole-exome sequencing for detecting exome variants.在检测外显子变异方面,全基因组测序比全外显子测序更强大。
Proc Natl Acad Sci U S A. 2015 Apr 28;112(17):5473-8. doi: 10.1073/pnas.1418631112. Epub 2015 Mar 31.
10
A clinically validated whole genome pipeline for structural variant detection and analysis.临床验证的全基因组结构变异检测和分析管道。
BMC Genomics. 2019 Jul 16;20(Suppl 8):545. doi: 10.1186/s12864-019-5866-z.

引用本文的文献

1
Genetic Investigation of Inherited Variants in a Multiplex Autism Spectrum Disorder (ASD) Family Using Whole-Genome Sequencing (WGS).使用全基因组测序(WGS)对一个多重自闭症谱系障碍(ASD)家系中的遗传变异进行基因研究。
Iran J Public Health. 2025 May;54(5):1087-1097. doi: 10.18502/ijph.v54i5.18643.
2
Systematic genetic assessment of hearing loss using whole-genome sequencing identifies pathogenic variants.使用全基因组测序对听力损失进行系统的遗传评估可识别出致病变异。
Exp Mol Med. 2025 Apr;57(4):775-787. doi: 10.1038/s12276-025-01428-x. Epub 2025 Apr 1.
3
SMARTER-database: a tool to integrate SNP array datasets for sheep and goat breeds.

本文引用的文献

1
Systematic dissection of biases in whole-exome and whole-genome sequencing reveals major determinants of coding sequence coverage.系统剖析全外显子组测序和全基因组测序中的偏倚揭示了编码序列覆盖的主要决定因素。
Sci Rep. 2020 Feb 6;10(1):2057. doi: 10.1038/s41598-020-59026-y.
2
Advances in genetic testing and optimization of clinical management in children and adults with epilepsy.遗传检测的进展和儿童及成人癫痫患者临床管理的优化。
Expert Rev Neurother. 2020 Mar;20(3):251-269. doi: 10.1080/14737175.2020.1713101. Epub 2020 Jan 27.
3
fastp: an ultra-fast all-in-one FASTQ preprocessor.
SMARTER数据库:一种整合绵羊和山羊品种SNP阵列数据集的工具。
GigaByte. 2024 Oct 21;2024:gigabyte139. doi: 10.46471/gigabyte.139. eCollection 2024.
4
Evaluation of whole genome sequencing utility in identifying driver alterations in cancer genome.评估全基因组测序在识别癌症基因组中驱动突变中的应用。
Sci Rep. 2024 Oct 12;14(1):23898. doi: 10.1038/s41598-024-74272-0.
5
Spatial resolved transcriptomics reveals distinct cross-talk between cancer cells and tumor-associated macrophages in intrahepatic cholangiocarcinoma.空间分辨转录组学揭示了肝内胆管癌中癌细胞与肿瘤相关巨噬细胞之间独特的相互作用。
Biomark Res. 2024 Sep 11;12(1):100. doi: 10.1186/s40364-024-00648-z.
6
From haystack to high precision: advanced sequencing methods to unraveling circulating tumor DNA mutations.从大海捞针到高精度:用于揭示循环肿瘤DNA突变的先进测序方法
Front Mol Biosci. 2024 Aug 6;11:1423470. doi: 10.3389/fmolb.2024.1423470. eCollection 2024.
7
Utility of genome sequencing in exome-negative pediatric patients with neurodevelopmental phenotypes.基因组测序在神经发育表型的外显子阴性儿科患者中的应用。
Am J Med Genet A. 2024 Dec;194(12):e63817. doi: 10.1002/ajmg.a.63817. Epub 2024 Jul 19.
8
Resolving unsolved whole-genome sequencing data in paediatric neurological disorders: a cohort study.解决儿科神经发育障碍全基因组测序数据未解决问题:一项队列研究。
Arch Dis Child. 2024 Aug 16;109(9):730-735. doi: 10.1136/archdischild-2024-326985.
9
Novel mutation leading to splice donor loss in a conserved site of gene causes Duchenne muscular dystrophy with cryptorchidism.新型突变导致基因保守部位的剪接受体位点丢失,引起伴有隐睾的杜氏肌营养不良症。
J Med Genet. 2024 Jul 19;61(8):741-749. doi: 10.1136/jmg-2024-109896.
10
Accelerated somatic mutation calling for whole-genome and whole-exome sequencing data from heterogenous tumor samples.加速体突变调用来自异质肿瘤样本的全基因组和全外显子组测序数据。
Genome Res. 2024 May 15;34(4):633-641. doi: 10.1101/gr.278456.123.
fastp:一个超快速的一体化 FASTQ 预处理程序。
Bioinformatics. 2018 Sep 1;34(17):i884-i890. doi: 10.1093/bioinformatics/bty560.
4
Whole-genome sequencing analysis of CNV using low-coverage and paired-end strategies is efficient and outperforms array-based CNV analysis.采用低覆盖度和双端测序策略进行全基因组测序分析,效率高,优于基于阵列的 CNV 分析。
J Med Genet. 2018 Nov;55(11):735-743. doi: 10.1136/jmedgenet-2018-105272. Epub 2018 Jul 30.
5
Clinical genome sequencing in an unbiased pediatric cohort.对无偏倚儿科队列进行临床基因组测序。
Genet Med. 2019 Feb;21(2):303-310. doi: 10.1038/s41436-018-0075-8. Epub 2018 Jul 16.
6
Measuring coverage and accuracy of whole-exome sequencing in clinical context.测量临床环境下全外显子组测序的覆盖度和准确性。
Genet Med. 2018 Dec;20(12):1617-1626. doi: 10.1038/gim.2018.51. Epub 2018 Apr 12.
7
Exome and genome sequencing in reproductive medicine.生殖医学中的外显子组和基因组测序。
Fertil Steril. 2018 Feb;109(2):213-220. doi: 10.1016/j.fertnstert.2017.12.010. Epub 2018 Feb 1.
8
Whole Genome Sequencing Expands Diagnostic Utility and Improves Clinical Management in Pediatric Medicine.全基因组测序扩大了诊断效用并改善了儿科医学的临床管理。
NPJ Genom Med. 2016 Jan 13;1:15012-. doi: 10.1038/npjgenmed.2015.12.
9
Comprehensive performance comparison of high-resolution array platforms for genome-wide Copy Number Variation (CNV) analysis in humans.用于人类全基因组拷贝数变异(CNV)分析的高分辨率阵列平台的综合性能比较
BMC Genomics. 2017 Apr 24;18(1):321. doi: 10.1186/s12864-017-3658-x.
10
Clinical Practice Guidelines for Rare Diseases: The Orphanet Database.罕见病临床实践指南:欧睿罕病数据库
PLoS One. 2017 Jan 18;12(1):e0170365. doi: 10.1371/journal.pone.0170365. eCollection 2017.